GLORIA BLOCK: Open Payments
NPI 1528093978 · ENDWELL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 45 payments from 11 companies in 2025. Trend: 2023 $960 · 2024 $907 · 2025 $787
Food & beverage: $787
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $291 |
| Novo Nordisk Inc | 9 | $135 |
| Phathom Pharmaceuticals, Inc. | 6 | $104 |
| Amgen Inc. | 4 | $64 |
| Lilly USA, LLC | 3 | $47 |
| Edwards Lifesciences Corporation | 1 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Verona Pharma, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
Products named: VRAYLAR, VOQUEZNA, Ozempic, Rybelsus, QULIPTA, UBRELVY, OTEZLA, MOUNJARO.
Industry payments across NY — which companies pay providers there.
